SCHEMBL23727976

SCHEMBL23727976

CC(C)(C)OC(=O)NCc1cccc(-n2ccsc2=NC(=O)c2c[nH]c3ncccc23)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LATS1 O95835 1/20 0.55
▸ LATS2 Q9NRM7 1/20 0.55
▸ BRD4 O60885 2/20 0.39
▸ MAP2K1 Q02750 1/20 0.37
▸ ADORA2A P29274 1/20 0.37
▸ PKM P14618 1/20 0.36
▸ CREBBP Q92793 1/20 0.35
▸ GLS O94925 2/20 0.35
▸ NAMPT P43490 1/20 0.35
▸ L3MBTL1 Q9Y468 2/20 0.34
▸ CYP3A4 P08684 1/20 0.34
▸ GFER P55789 1/20 0.34
▸ HSD17B10 Q99714 1/20 0.34
▸ KDR P35968 1/20 0.34
▸ AKT1 P31749 1/20 0.34
▸ PDPK1 O15530 2/20 0.33
▸ CDC7 O00311 1/20 0.33
▸ ROCK2 O75116 1/20 0.33
▸ PIM1 P11309 1/20 0.33
▸ PRKACA P17612 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23727973 1.00 LATS1 (0.55) LATS1LATS2BRD4MAP2K1ADORA2A
SCHEMBL23727975 1.00 LATS1 (0.55) LATS1LATS2BRD4MAP2K1ADORA2A
SCHEMBL30130869 1.00 LATS1 (0.55) LATS1LATS2BRD4MAP2K1ADORA2A
SCHEMBL23727497 0.88 LATS1 (0.64) LATS1LATS2MAP2K1ADORA2APKM
SCHEMBL23727499 0.88 LATS1 (0.64) LATS1LATS2MAP2K1ADORA2APKM
SCHEMBL23727208 0.84 LATS1 (0.63) LATS1LATS2MAP2K1ADORA2APKM
SCHEMBL30130820 0.84 LATS1 (0.63) LATS1LATS2MAP2K1ADORA2APKM
SCHEMBL23727206 0.84 LATS1 (0.63) LATS1LATS2MAP2K1ADORA2APKM
SCHEMBL23749898 0.82 LATS1 (0.57) LATS1LATS2MAP2K1CYP3A4KDR
SCHEMBL23750053 0.82 LATS1 (0.58) LATS1LATS2MAP2K1CDC7ROCK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12617785-B2 Pyrrolo[2,3-b]pyridine-3-carboxamide compositions and methods for ameliorating hearing loss THE ROCKEFELLER UNIVERSITY (US) 2026-05-05 — — US disclosed
EP-4100008-B1 PYRROLO [2,3-B]PYRIDINE-3-CARBOXAMIDE COMPOSITIONS AND METHODS FOR AMELIORATING HEARING LOSS UNIV ROCKEFELLER (US) 2025-04-02 — — EP disclosed
US-20230137893-A1 PYRROLO[2,3-b]PYRIDINE-3-CARBOXAMIDE COMPOSITIONS AND METHODS FOR AMELIORATING HEARING LOSS THE ROCKEFELLER UNIVERSITY (US) 2023-05-04 — — US disclosed
EP-4100008-A1 PYRROLO [2,3-B]PYRIDINE-3-CARBOXAMIDE COMPOSITIONS AND METHODS FOR AMELIORATING HEARING LOSS The Rockefeller University (US) 2022-12-14 — — EP disclosed
WO-2021158936-A1 PYRROLO [2,3-B]PYRIDINE-3-CARBOXAMIDE COMPOSITIONS AND METHODS FOR AMELIORATING HEARING LOSS THE ROCKEFELLER UNIVERSITY (US) 2021-08-12 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12617785-B2 Pyrrolo[2,3-b]pyridine-3-carboxamide compositions and methods for ameliorating hearing loss YAP1, LATS2, LATS1 LATS1 3/4885LATS2 2/4885BRD4 813/4885
US-20230137893-A1 PYRROLO[2,3-b]PYRIDINE-3-CARBOXAMIDE COMPOSITIONS AND METHODS FOR AMELIORATING HEARING LOSS LATS2, LATS1, YAP1 LATS1 2/4885LATS2 1/4885BRD4 459/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback